Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, 163 Horreya Avenue, Chatbye, P.O.Box 832, Alexandria, Egypt.
Pharmaceutical Bioproducts Research Department, Genetic Engineering & Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria, Egypt.
BMC Complement Med Ther. 2020 Mar 12;20(1):79. doi: 10.1186/s12906-020-2876-y.
In the context of searching for potent, safe, natural antimicrobial agents to combate the global antimicrobial resistance (AMR) phenomenon, the current study evaluates for the first time ever, the broad-spectrum antimicrobial activity of essential oil (EO) and extracts from the rare wild plant Centaurea pumilio L.. It has tremendous ethnomedicinal values; its dried root is used as a fattening agent, a treatment for bad breath and diabetes, and screened for schistosomicidal activity.
C. pumilio EO was extracted by hydrodistillation using a Clevenger apparatus. Chemical constituents of aerial part were extracted using a sequential solvent/solvent procedure employing four solvents with increasing polarities in the following order: petroleum ether, chloroform, ethyl acetate, and n-butanol. The chemical constituents were identified by GC-MS. Fifty-two microbial strains were used; twenty-six multidrug resistant (MDR), sixteen clinical, and ten reference strains. The identification of the microbial strains was performed by MALDI-TOF-MS. The antimicrobial activity of the EO and the aerial part and the root extracts was assessed through disc diffusion assay. A minimum inhibitory concentration (MIC) of the EO and extracts was determined using the broth micro-dilution method.
The growth of reference and clinical strains was inhibited by EO, methanol, chloroform, and ethyl acetate aerial part extracts and chloroform root extract. The MDR strains growth, however, was inhibited only by EO and chloroform aerial part extract. GC-MS identified for the first time eighteen constituents from aerial part EO and chloroform extract each. EO showed antimicrobial activity against the reference, clinical, and MDR strains with MIC values of 31.25-125, 31.25-125, and 62.50-250 μg/mL, respectively. Methanol aerial part extract exhibited high antimicrobial activities with MIC values of 62.50-250 μg/mL against reference and clinical strains. Chloroform root extract displayed strong antimicrobial activity against reference and clinical strains recording MIC values of 62.50-250 μg/mL and 62.50-125 μg/mL, respectively. The chloroform aerial part extract demonstrated potent antimicrobial activity against the reference, clinical, and MDR strains with 31.25, 31.25, and 15.62 μg/mL MIC values, respectively.
Present data unravel the C. pumilio pharmacological magnitude to discover eco-friendly potent antimicrobial agents to fight AMR phenomenon.
在寻找有效、安全、天然的抗菌剂以应对全球抗菌药物耐药性(AMR)现象的背景下,本研究首次评估了珍稀野生植物矢车菊精油(EO)及其提取物的广谱抗菌活性。该植物具有巨大的民族医学价值,其干根可用作催肥剂、口臭和糖尿病的治疗剂,并筛选其杀血吸虫活性。
采用水蒸气蒸馏法(Clevenger 装置)从地上部分提取 EO。采用顺序溶剂/溶剂法,使用四种极性逐渐增加的溶剂(石油醚、氯仿、乙酸乙酯和正丁醇)提取地上部分的化学成分。采用 GC-MS 鉴定化学成分。使用了 52 株微生物菌株,其中 26 株为多药耐药(MDR)菌株,16 株为临床菌株,10 株为参考菌株。采用 MALDI-TOF-MS 对微生物菌株进行鉴定。通过纸片扩散法评估 EO 以及地上部分和根提取物的抗菌活性。采用肉汤微量稀释法测定 EO 和提取物的最小抑菌浓度(MIC)。
EO、甲醇、氯仿和乙酸乙酯地上部分提取物以及氯仿根提取物均抑制参考菌株和临床菌株的生长,而 MDR 菌株的生长仅被 EO 和氯仿地上部分提取物抑制。GC-MS 首次从地上部分 EO 和氯仿提取物中各鉴定出 18 种成分。EO 对参考菌株、临床菌株和 MDR 菌株均具有抗菌活性,MIC 值分别为 31.25-125、31.25-125 和 62.50-250μg/mL。甲醇地上部分提取物对参考菌株和临床菌株表现出高抗菌活性,MIC 值分别为 62.50-250μg/mL。氯仿根提取物对参考菌株和临床菌株显示出较强的抗菌活性,MIC 值分别为 62.50-250μg/mL 和 62.50-125μg/mL。氯仿地上部分提取物对参考菌株、临床菌株和 MDR 菌株的 MIC 值分别为 31.25、31.25 和 15.62μg/mL,具有较强的抗菌活性。
目前的数据揭示了矢车菊的药理学重要性,以发现环保型、强效的抗菌剂来对抗 AMR 现象。